Last updated on June 2016

Wingspan® StEnt System Post MArket SurVEillance Study


Brief description of study

Wingspan® StEnt System Post MArket SurVEillance Study

Detailed Study Description

The Wingspan® Stent System with Gateway® Percutaneous Transluminal Angioplasty (PTA)

Balloon Catheter was approved in the United States (US) under a Humanitarian Device

Exemption (HDE) and received CE Mark in 2005.

This study is being conducted to fulfill Food and Drug Administration (FDA) post market safety

surveillance requirements

Clinical Study Identifier: TX143963

Contact Investigators or Research Sites near you

Start Over

Jenny Martin

Baptist Health Lexington Clinical Research Center
Lexington, KY USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.